Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neurofibromatosis 2 × Everolimus × Clear all

Phase

Phase 2 3 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Xerostomia 1 Recurrence 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Mouth Neoplasms 1 Meningioma 1 Head and Neck Neoplasms 1 Glioma 1 Brain Neoplasms 1

Interventions

Lapatinib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01880749 2020-05-13

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

NYU Langone Health

Phase EARLY_PHASE1 Completed

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡